Myocardium at Risk After Acute Infarction in Humans on Cardiac Magnetic Resonance. Quantitative Assessment During Follow-Up and Validation With Single-Photon Emission Computed Tomography

JACC: Cardiovascular Imaging

Volumn 2, Issue 5, 2009, Pages 569-576

  Carlsson, Marcus ^a   Ubachs, Joey F A ^a   Hedström, Erik ^a   Heiberg, Einar ^a   Jovinge, Stefan ^a   Arheden, Håkan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CMR; myocardium at risk; salvaged myocardium; T2 STIR

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; GADOLINIUM; TETROFOSMIN TC 99M;

ACCURACY; ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY STENT; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE REPERFUSION; HUMAN; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT ELEVATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HETEROCYCLIC COMPOUNDS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 65549119248     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2008.11.018     Document Type: Article

References (31)

1. Hedstrom E., Frogner F., Åström-Olsson K., Öhlin H., and Arheden H. Myocardial infarct size in relation to myocardium at risk versus duration of ischemia in humans: comparison with different species (abstr). J Cardiovasc Magn Reson 9 (2007) 363
2. Feiring A.J., Johnson M.R., Kioschos J.M., Kirchner P.T., Marcus M.L., and White C.W. The importance of the determination of the myocardial area at risk in the evaluation of the outcome of acute myocardial infarction in patients. Circulation 75 (1987) 980-987
3. Lowe J.E., Reimer K.A., and Jennings R.B. Experimental infarct size as a function of the amount of myocardium at risk. Am J Pathol 90 (1978) 363-379
4. Kloner R.A., Bolli R., Marban E., Reinlib L., and Braunwald E. Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. Circulation 97 (1998) 1848-1867
5. Gibbons R.J., Valeti U.S., Araoz P.A., and Jaffe A.S. The quantification of infarct size. J Am Coll Cardiol 44 (2004) 1533-1542
6. Arheden H., Saeed M., Higgins C.B., et al. Reperfused rat myocardium subjected to various durations of ischemia: estimation of the distribution volume of contrast material with echo-planar MR imaging. Radiology 215 (2000) 520-528
7. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 (1999) 1992-2002
8. Carlsson M., Wijns W., Arheden H., Higgins C., and Saeed M. Magnetic resonance imaging as a potential gold standard for infarct quantification. J Electrocardiol 41 (2008) 614-620
9. De Coster P.M., Wijns W., Cauwe F., Robert A., Beckers C., and Melin J.A. Area-at-risk determination by technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction. Circulation 82 (1990) 2152-2162
10. Gibbons R.J., Verani M.S., Behrenbeck T., et al. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation 80 (1989) 1277-1286
11. Sinusas A.J., Trautman K.A., Bergin J.D., et al. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. Circulation 82 (1990) 1424-1437
12. Garcia-Dorado D., Oliveras J., Gili J., et al. Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. Cardiovasc Res 27 (1993) 1462-1469
13. Fishbein M.C., Maclean D., and Maroko P.R. The histopathologic evolution of myocardial infarction. Chest 73 (1978) 843-849
14. Aletras A.H., Tilak G.S., Natanzon A., et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 113 (2006) 1865-1870
15. Tilak G.S., Hsu L.Y., Hoyt Jr. R.F., Arai A.E., and Aletras A.H. In vivo T2-weighted magnetic resonance imaging can accurately determine the ischemic area at risk for 2-day-old nonreperfused myocardial infarction. Invest Radiol 43 (2008) 7-15
16. Abdel-Aty H., Zagrosek A., Schulz-Menger J., et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 109 (2004) 2411-2416
17. 201TlCl single photon emission computed tomography. Circ J 68 (2004) 1023-1029
18. Soneson H., Ubachs J., Ugander M., Arheden J., and Heiberg E. An improved method for automatic segmentation of the left ventricle in myocardial perfusion SPECT. J Nucl Med 50 (2009) 205-213
19. Heiberg E., Ugander M., Engblom H., et al. Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. Radiology 246 (2008) 581-588
20. Stork A., Muellerleile K., Bansmann P.M., et al. Value of T2-weighted, first-pass and delayed enhancement, and cine CMR to differentiate between acute and chronic myocardial infarction. Eur Radiol 17 (2007) 610-617
21. Friedrich M.G., Abdel-Aty H., Taylor A., Schulz-Menger J., Messroghli D., and Dietz R. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol 51 (2008) 1581-1587
22. Stork A., Lund G.K., Muellerleile K., et al. Characterization of the peri-infarction zone using T2-weighted MRI and delayed-enhancement MRI in patients with acute myocardial infarction. Eur Radiol 16 (2006) 2350-2357
23. Saeed M., Wagner S., Wendland M.F., Derugin N., Finkbeiner W.E., and Higgins C.B. Occlusive and reperfused myocardial infarcts: differentiation with Mn-DPDP-enhanced MR imaging. Radiology 172 (1989) 59-64
24. Steenbergen C., Hill M.L., and Jennings R.B. Volume regulation and plasma membrane injury in aerobic, anaerobic, and ischemic myocardium in vitro. Effects of osmotic cell swelling on plasma membrane integrity. Circ Res 57 (1985) 864-875
25. Arheden H., Saeed M., Higgins C.B., et al. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 211 (1999) 698-708
26. Zhao Z.Q., Corvera J.S., Halkos M.E., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285 (2003) H579-H588
27. Reimer K.A., Lowe J.E., Rasmussen M.M., and Jennings R.B. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 56 (1977) 786-794
28. Ibanez B., Prat-Gonzalez S., Speidl W.S., et al. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation 115 (2007) 2909-2916
29. Adams G.L., Shaw L.K., Tuttle R.H., Hanson M.W., Pagnanelli R., and Borges-Neto S. Prediction of mortality in patients with coronary artery disease undergoing vasodilator stress testing: a comparison between 99mTc-tetrofosmin and 99mTc-sestamibi. Nucl Med Commun 28 (2007) 457-463
30. Kellman P., Aletras A.H., Mancini C., McVeigh E.R., and Arai A.E. T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo. Magn Reson Med 57 (2007) 891-897
31. Aletras A.H., Kellman P., Derbyshire J.A., and Arai A.E. ACUT2E TSE-SSFP: a hybrid method for T2-weighted imaging of edema in the heart. Magn Reson Med 59 (2008) 229-235